Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.615    -0.035 (-0.75%)
Bid:
4.61
Ask:
4.68
Spread: 0.07 (1.518%)
Market Cap: £221.50m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

NEW FACEAPI PRODUCT RELEASE

26 Aug 2008 08:33

RNS Number : 9816B
Seeing Machines Limited
26 August 2008
 



26 August 2008

Seeing Machines Limited

("Seeing Machines" or the "Company")

SEEING MACHINES ANNOUNCES NEW FACEAPI PRODUCT RELEASE

Seeing Machines (AIM: SEE), a leading developer of advanced computer based imaging software systems, yesterday released a new version of its faceAPI product, a face tracking toolkit for Original Equipment Manufacturers (OEM's) and application developers that turns a web camera into a 3D face tracking device.  The product was released at NVISION 08 NVIDIA's visual computing conference held in San Jose California this week.

"The new release of the faceAPI boasts a large number of new features and improvements. We have delivered on requests from our partners and customers, and then some" said Nick Langdale-Smith, Director of Sales and Marketing for Seeing Machines. "One of the major additions is the unique ability to track lip and eyebrow movements, enabling games and virtual worlds to read a user's facial expression, as well as head orientation and movement". 

Dr Nick Cerneaz, CEO of Seeing Machines commenting on the release said "This release of the faceAPI product is a very important part of our long term strategy. We expect this version of the faceAPI to be the springboard for the commercial success of this product".

Further information about Seeing Machines and faceAPI can be obtained from the Company web site: www.seeingmachines.com.

--- ENDS ---

Enquiries:

Seeing Machines Limited

Grant Thornton UK LLP

Parkgreen Communications

Nick Cerneaz, CEO

Fiona Owen

Paul McManusHelen Westaway

+61 (0) 2 6125 6501

+44 (0) 20 7383 5100

+44 (0) 20 7851 7480

www.seeingmachines.com

  Notes to editors:

About Seeing Machines

Seeing Machines is an award winning Technology Company which focuses on vision based human machine interfaces. Formed in 2000 in CanberraAustralia, Seeing Machines purpose is to commercialize its computer-vision across a range of industries and applications. 

Seeing Machines delivers advanced computer vision solutions for researchers and developers in human factors, transportation safety, entertainment, computer human interaction, robotics and medical research. 

Seeing Machines computer vision systems are able to measure the orientation and position of a human head, estimate eye-gaze direction, detect eye blinks and track other facial features. This functionality is achieved entirely though visual means, using video cameras connected to advanced image processing software, with no attachments required on the subject. The faceAPI® product encapsulates the core of Seeing Machines computer-vision algorithms into a package designed for licensing to OEM's and third-parties.

The flagship product faceLAB® provides an automated and contact-free gaze and head tracking technology, it solves the problem of observing human behaviour naturally, non-intrusively and with a high degree of accuracy and usability. Building on these unique face tracking and pupil measurement and monitoring capabilities, the TrueField Analyzer® is new medical device to assist clinicians detect and manage eye diseases such as glaucoma.

The TrueField Analyzer® offers a new objective method to help doctors diagnose and manage a range of eye diseases including glaucoma, age related macular degeneration and diabetic retinopathy. Glaucoma affects about 2-3% of the population over 40 years of age and is a leading source of blindness. Unlike most other devices available to the clinician the TrueField Analyzer is a completely objective test and it is quick and easy for patients and technicians alike. The device measures both eyes concurrently and due to the reliability that arises from the objective nature of the test, it has the potential to become a new standard in the measurement of visual field defects and thus in the diagnosis and management of disease such as glaucoma.

The Driver State Sensor is driver monitoring software targeted at the detection of fatigue and distraction in drivers and operators. The DSS detects drowsiness (fatigue) or that the driver is distracted and their attention has been diverted from the road, alarms are raised to alert the driver to these events. In larger deployments, such as in fleet and mining equipment operations, the data is available in both real-time and off-line modes for fleet management, driver training and awareness programs

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLGRGDIDXDGGIL
Date   Source Headline
16th Mar 202311:12 amRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSPDMR Shareholding
14th Mar 20237:00 amRNSPDMR Shareholding
13th Mar 20239:24 amRNSNo exposure to Silicon Valley Bank
9th Mar 20236:09 pmRNSDirector/PDMR Shareholding
8th Mar 20233:33 pmRNSDirector/PDMR Shareholding
8th Mar 20233:30 pmRNSDirector/PDMR Shareholding
6th Mar 20237:00 amRNSHalf year results and financial report
22nd Feb 20237:00 amRNSHalf year trading update and quarterly KPIs
15th Feb 20237:00 amRNSNotice of Results & Investor Presentation
8th Feb 20239:46 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSSeeing Machines and Mobileye to target Aftermarket
26th Jan 20239:36 amRNSDirector/PDMR Shareholding
25th Jan 202310:24 amRNSDirector/PDMR Shareholding
16th Jan 202310:28 amRNSDirector/PDMR Shareholding
13th Jan 20238:50 amRNSDirector/PDMR Shareholding
12th Jan 202310:05 amRNSDirector/PDMR Shareholding
11th Jan 202311:19 amRNSDirector/PDMR Shareholding
5th Jan 20237:00 amRNSLaunch of Silicon Platform with OMNIVISION
4th Jan 20237:00 amRNSThree Collaborations to be showcased at CES 2023
3rd Jan 20237:00 amRNSSeeing Machines to exhibit DMS & OMS at CES 2023
22nd Dec 20227:02 amRNSSeeing Machines awarded additional OEM program
7th Dec 20229:01 amRNSPDMR Shareholding
6th Dec 20228:58 amRNSPDMR Shareholding
5th Dec 20227:00 amRNSPDMR Shareholding
2nd Dec 20227:00 amRNSPDMR Shareholding
29th Nov 20223:31 pmEQSSeeing Machines CEO talks new performance indicators and focus on annual growth
29th Nov 202210:43 amRNSPDMR Shareholding
28th Nov 20228:53 amRNSResult of AGM
24th Nov 202212:43 pmRNSPDMR Shareholding
23rd Nov 20227:00 amRNSKey Performance Indicators Q1 FY 2023
21st Nov 202211:46 amRNSPDMR Shareholding
18th Nov 20227:00 amRNSPDMR Shareholding
16th Nov 20227:00 amRNSPDMR Shareholding
14th Nov 20227:00 amRNSPDMR Shareholding
11th Nov 20227:00 amRNSAppointment of Chief Financial Officer
1st Nov 202211:17 amRNSDirector/PDMR Shareholding
27th Oct 20228:18 amRNSNotice of AGM
27th Oct 20227:00 amRNSYear End Results – FY2022
6th Oct 20227:00 amRNSExclusive agreement with Magna & US$65m investment
15th Sep 20228:50 amRNSTown Hall (Revised Date)
9th Sep 20227:30 amRNSPostponement of London presentation
16th Aug 20227:00 amRNSSeeing Machines London presentation
15th Aug 20227:00 amRNSFY2022 trading update
2nd Aug 202212:30 pmRNSInvestor newsletter update
16th Jun 20227:00 amRNSSeeing Machines awarded additional OEM program
6th Jun 20227:22 amRNSNew Tier One contract takes OEM customers to 10
10th May 20227:00 amRNSSeeing Machines appointment with Japanese OEM
9th May 20227:00 amRNSSeeing Machines collaboration in optics technology
21st Apr 20227:00 amRNSCollaboration with leading systems supplier

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.